Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Toward a mechanism-based in vitro safety test for pertussis toxin.

Vaessen SF, Bruysters MW, Vandebriel RJ, Verkoeijen S, Bos R, Krul CA, Akkermans AM.

Hum Vaccin Immunother. 2014;10(5):1391-5. doi: 10.4161/hv.28001. Epub 2014 Feb 19. Review.

2.

Identification of biomarkers to detect residual pertussis toxin using microarray analysis of dendritic cells.

Vaessen SF, Verkoeijen S, Vandebriel RJ, Bruysters MW, Pennings JL, Bos R, Krul CA, Akkermans AM.

Vaccine. 2013 Oct 25;31(45):5223-31. doi: 10.1016/j.vaccine.2013.08.082. Epub 2013 Sep 18.

PMID:
24055089
3.

An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis.

van Nimwegen MJ, Verkoeijen S, Kuppen PJ, Velthuis JH, van de Water B.

Clin Exp Metastasis. 2007;24(5):379-87. Epub 2007 May 31.

PMID:
17541710
4.

Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.

van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B.

Cancer Res. 2005 Jun 1;65(11):4698-706.

5.

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

Meij P, Leen A, Rickinson AB, Verkoeijen S, Vervoort MB, Bloemena E, Middeldorp JM.

Int J Cancer. 2002 May 1;99(1):93-9.

Supplemental Content

Loading ...
Support Center